Home > BIGG > Search result

    Results: 3

    AGA clinical practice guideline on the role of biomarkers for the management of Crohn’s Disease

    Adler, Jeremy; Ananthakrishnan, Ashwin N; Chachu, Karen A; Cohen, Benjamin L; Nguyen, Nghia H; Siddique, Shazia M; Singh, Siddharth; Sultan, Shahnaz; Velayos, Fernando S; Weiss, Jennifer M.
    Gastroenterology; 6 (165), 2023
    Biomarkers are used frequently for evaluation and monitoring of patients with Crohn’s disease (CD). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the management of CD. A multidisciplinary panel of content ...
    Inflammatory Bowel Diseases/diagnosis, Endoscopy, Gastrointestinal, Leukocyte L1 Antigen Complex/analysis, Remission Induction, Inflammatory Bowel Diseases/diagnostic imaging, C-Reactive Protein/analysis
    Fulltext

    WHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease

    World Health Organization.
    Tuberculosis (TB) is a leading cause of death from a single infectious agent, despite being largely curable and preventable. In 2019 an estimated 2.9 million of the 10 million people who fell ill with TB were not diagnosed or reported to the World Health Organization. The Political Declaration adopted by...
    Tuberculosis/diagnostic imaging, Risk Groups, Risk Factors, Radiography, Tuberculosis/diagnosis, C-Reactive Protein/analysis
    Fulltext

    Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy

    Dent, S; Brezden-Masley, C; Clarke, B; Davis, MK; Jassal, DS; Johnson, C; Lemieux, J; Paterson, I; Sebag, IA; Simmons, C; Sulpher, J; Thain, K; Thavendiranathan, P; Wentzell, JR; Wurtele, N; Côté, MA; Fine, NM; Haddad, H; Hayley, BD; Hopkins, S; Joy, AA; Rayson, D; Stadnick, E; Straatman, L; Virani, SA.
    Can. j. cardiol; 32 (7), 2016
    Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This ...
    Antineoplastic Agents, Biomarkers, Cardiotonic Agents, Cardiotoxins, Troponin T, Natriuretic Peptide, Brain, C-Reactive Protein, Antineoplastic Agents/adverse effects, Arrhythmias, Cardiac, Cardiotoxicity, Coronary Thrombosis, Early Diagnosis, Echocardiography, Three-Dimensional, Hypertension/therapy, Magnetic Resonance Imaging, Cine, Myocardial Ischemia, Neoplasms/therapy, Primary Prevention, Radiotherapy, Risk Factors, Ventricular Dysfunction, Left, Cardiotoxicity/diagnosis, Cardiotoxins/adverse effects, Radiotherapy/adverse effects
    Fulltext